An expert from FourKites shares impacts of the February storm that hit Texas and other parts of North America, and lessons can be learned from the event.
How can a pharma company invest in continuous manufacturing without bleeding money when it retreats from a local market? Pfizer’s answer is production pods it can roll out anywhere in the world via helicopter… and pack away again if a market turns.
Efforts to address the current shortage of IV fluids in the US are a placing a strain on manufacturing capabilities according to Baxter, which is investing to try and increase production capacity.
Chinese CRO Wuxi Pharmatech posted impressive revenue growth for Q2 driven by demand for lab services, but the firm still faced margin pressure due partly to rising labour costs.
No job losses, facility divestitures or strategic changes are planned at DPT Laboratories according to new owner Renaissance Pharma, which bought the CDMO in an out-of-the-blue deal last week.
The contract service market failed to recover as hoped in 2010 and consequently many companies made cutbacks. Outsourcing-Pharma rounds up five of the most read of 2010.
Vetter Pharma have begun construction of its latest storage facility in a move that forms part of Vetter’s recent efforts to expand its pharmaceutical logistical resources. Vetter's newest facility, located in Germany, adds to another new U.S facility...
Increasing customer demand for integrated and flexible systems were the drivers behind developing new vertical flat pouch equipment for packing a range of free-flowing goods including granulates and powders, said Bosch Packaging Technology.
US CRO Charles River Laboratories (CRL) will halt operations at its preclinical services (PCS) facility in Massachusetts until demand for early-stage drug development recovers.
SAFC Pharma, the contract manufacturing arm of Sigma-Aldrich, has
announced it has completed the construction of two protein active
pharmaceutical ingredient (API) facilities at its US manufacturing
site.
Fine chemical and pharmaceutical intermediate manufacturers may be
affected by supply disruptions due to ongoing UK shortages of
natural gas. Price spikes in gas are becoming both higher and more
frequent in the UK.
German chemicals giant BASF reported strong earnings increases
across the board yesterday, helped by pricing increases. The
companies activities in pharmaceuticals, part of its chemicals and
fine chemicals units, also did well, report...
